Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Strength Seen in Seattle Genetics (SGEN): Can Its 14.5% Jump Turn into More Strength?
06:07am, Tuesday, 14'th Mar 2023
Seattle Genetics (SGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price incre
How Pfizer's $43 billion acquisition of Seagen could impact the biotech industry in Seattle
09:52pm, Monday, 13'th Mar 2023
Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed.
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
07:15pm, Monday, 13'th Mar 2023
Markets were mixed on a volatile day on Wall Street. Sanofi offered to buy Provention Bio at a price more than triple where the stock closed Friday.
Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions
05:34pm, Monday, 13'th Mar 2023
Last week ended on a hectic note
Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion
04:41pm, Monday, 13'th Mar 2023
Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pha
Pfizer offers $43 billion to buy cancer drugmaker Seagen
03:24pm, Monday, 13'th Mar 2023
CNBC's Meg Tirrell joins 'Power Lunch' to discuss Pfizer's acquisition of Seagen, the reasoning behind the $43 billion biotech deal, and more.
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal
01:48pm, Monday, 13'th Mar 2023
Pfizer CEO Albert Bourla said it will deliver Seagen's cancer therapy to the world at a scale that hasn't been seen before with its $43 billion acquisition.
Pfizer Overpays for Seagen, but Who's Counting
01:37pm, Monday, 13'th Mar 2023
Acquiring top biotech assets as other big pharmaceutical companies face a patent cliff was bound to be expensive.
Seagen has one of the greatest technologies to battle cancer: Pfizer CEO on acquisition
12:25pm, Monday, 13'th Mar 2023
Albert Bourla, Pfizer CEO, joins 'Squawk on the Street' to discuss his thoughts on the company buying Seagen.
Pfizer Buying Seagen For $43 Billion: Details (PFE) (SGEN)
12:09pm, Monday, 13'th Mar 2023
Pfizer (NYSE: PFE) is buying Seagen Inc. (Nasdaq: SGEN) for $43 billion. These are the details.
Pfizer to pay $43B for Seagen, boosting cancer drug portfolio
11:58am, Monday, 13'th Mar 2023
The latest deal comes as Pfizer seeks to mitigate an anticipated $17 billion hit to revenue by 2030 from patent expirations for top drugs and decline in demand for its COVID products.
Why Seagen Stock Is Soaring Today
11:48am, Monday, 13'th Mar 2023
Pfizer plans to acquire Seagen for around $43 billion. Investors appear to have already been betting the deal would happen after several weeks of rumors about a potential buyout.
Seagen Stock Boosted on Billion-Dollar Buyout
11:41am, Monday, 13'th Mar 2023
Seagen Inc (NASDAQ:SGEN) stock is soaring today, after news that Pfizer (PFE) is acquiring the company for roughly $43 billion, expanding its access to cancer treatment.
Pfizer aiming to acquire Seagen in $43 billion deal
11:37am, Monday, 13'th Mar 2023
Yahoo Finance Live's Julie Hyman discusses reports that Pfizer is aiming to acquire Seagen in a $43 billion deal.
Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio
11:17am, Monday, 13'th Mar 2023
Here are some of the biggest movers on Monday with banks firmly in focus after federal regulators stepped into protect deposits at fallen bank SVB.
